Literature DB >> 15857123

Enantiomerically pure hexahydropyrazinoquinolines as potent and selective dopamine 3 subtype receptor ligands.

Ke Ding1, Jianyong Chen, Min Ji, Xihan Wu, Judith Varady, Chao-Yie Yang, Yipin Lu, Jeffrey R Deschamps, Beth Levant, Shaomeng Wang.   

Abstract

We report the design and synthesis of a series of enantiomerically pure hexahydropyrazinoquinolines as potent and selective ligands for the dopamine 3 subtype receptor using a newly developed synthetic method and using in vitro pharmacological evaluation. Our efforts yielded optically pure ligands with high affinities for the D(3) receptor and outstanding selectivity over closely related D(1)-like and D(2)-like receptors. For example, compound 38a has a K(i) value of 5.7 nM to the D(3) receptor and selectivity greater than 10000- and 1600-fold over the D(1)-like and D(2)-like receptors, respectively, and thus is one of the most selective D(3) ligands reported to date.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15857123     DOI: 10.1021/jm049031l

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  High-affinity and selective dopamine D₃ receptor full agonists.

Authors:  Jianyong Chen; Beth Levant; Shaomeng Wang
Journal:  Bioorg Med Chem Lett       Date:  2012-07-11       Impact factor: 2.823

2.  Design, synthesis, and evaluation of potent and selective ligands for the dopamine 3 (D3) receptor with a novel in vivo behavioral profile.

Authors:  Jianyong Chen; Gregory T Collins; Jian Zhang; Chao-Yie Yang; Beth Levant; James Woods; Shaomeng Wang
Journal:  J Med Chem       Date:  2008-09-12       Impact factor: 7.446

3.  New tetracyclic tetrahydro-beta-carbolines as tryptophan-derived peptidomimetics.

Authors:  Karolina Pulka; Debby Feytens; Aleksandra Misicka; Dirk Tourwé
Journal:  Mol Divers       Date:  2009-06-16       Impact factor: 2.943

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.